Efficacy and Toxicity of Hepatic Intra‐Arterial Drug‐Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan‐Refractory Unresectable Colorectal Liver Metastases
Efficacy and Toxicity of Hepatic Intra‐Arterial Drug‐Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan‐Refractory Unresectable Colorectal Liver Metastases is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy and Toxicity of Hepatic Intra‐Arterial Drug‐Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan‐Refractory Unresectable Colorectal Liver Metastases have?
Efficacy and Toxicity of Hepatic Intra‐Arterial Drug‐Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan‐Refractory Unresectable Colorectal Liver Metastases has 43 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy and Toxicity of Hepatic Intra‐Arterial Drug‐Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan‐Refractory Unresectable Colorectal Liver Metastases published?
Efficacy and Toxicity of Hepatic Intra‐Arterial Drug‐Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan‐Refractory Unresectable Colorectal Liver Metastases has 2015 year in the ScholarIQ index.
What is the open-access status of Efficacy and Toxicity of Hepatic Intra‐Arterial Drug‐Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan‐Refractory Unresectable Colorectal Liver Metastases?
Efficacy and Toxicity of Hepatic Intra‐Arterial Drug‐Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan‐Refractory Unresectable Colorectal Liver Metastases has closed oa status in the ScholarIQ index.
What is the DOI of Efficacy and Toxicity of Hepatic Intra‐Arterial Drug‐Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan‐Refractory Unresectable Colorectal Liver Metastases?
The DOI for Efficacy and Toxicity of Hepatic Intra‐Arterial Drug‐Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan‐Refractory Unresectable Colorectal Liver Metastases is on the source record.
What is the PMID of Efficacy and Toxicity of Hepatic Intra‐Arterial Drug‐Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan‐Refractory Unresectable Colorectal Liver Metastases?
The PMID for Efficacy and Toxicity of Hepatic Intra‐Arterial Drug‐Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan‐Refractory Unresectable Colorectal Liver Metastases is on the source record.
What is the OpenAlex record for Efficacy and Toxicity of Hepatic Intra‐Arterial Drug‐Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan‐Refractory Unresectable Colorectal Liver Metastases?
The OpenAlex for Efficacy and Toxicity of Hepatic Intra‐Arterial Drug‐Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan‐Refractory Unresectable Colorectal Liver Metastases is on the source record.